On May 1, 2025, Intuitive announced FDA clearance for its da Vinci Single Port (SP) surgical system to be used in transanal local excision/resection procedures. This minimally invasive technique allows surgeons to operate through a natural orifice, avoiding abdominal incisions. The da Vinci SP is designed for precise access in narrow anatomical spaces like the rectum, supporting improved ergonomics and patient outcomes. This new clearance builds on prior FDA approvals for colorectal and urology procedures and further expands Intuitive’s colorectal surgery portfolio. The announcement coincides with Intuitive's 30th anniversary and milestone of nearly 17 million procedures performed using its robotic systems.